Unique ID issued by UMIN | UMIN000010330 |
---|---|
Receipt number | R000012091 |
Scientific Title | Comprehensive assessment of chemotherapy-induced cognitive dysfunction in patients with breast cancer |
Date of disclosure of the study information | 2013/03/27 |
Last modified on | 2013/03/27 16:34:09 |
Comprehensive assessment of chemotherapy-induced cognitive dysfunction in patients with breast cancer
Asssement of chemobrain
Comprehensive assessment of chemotherapy-induced cognitive dysfunction in patients with breast cancer
Asssement of chemobrain
Japan |
patients with breast cancer
Breast surgery |
Malignancy
NO
To confirm the method how to assess cognitive dysfunction following to chemotherapy for breast cancer, and validate the biomaker
Efficacy
Cognitive function
Observational
20 | years-old | <= |
80 | years-old | >= |
Male and Female
Patients with breast cancer, who have received chemotherapy (including the aromatase inhibitor)
Patients with obvious neurological deficit before recieving chemotherapy
100
1st name | |
Middle name | |
Last name | Hideko Yamauchi |
St. Luke international hospital
Breast Center
Akashi 9-1, Chuouku, Tokyo, Japan
03-3541-5151
1st name | |
Middle name | |
Last name | Masahiko Sumitani |
The University of Tokyo Hospital
Department of Medical Engineering
St. Luke international hospital
MHLW
Japan
NO
聖路加国際病院(東京都)
2013 | Year | 03 | Month | 27 | Day |
Unpublished
Enrolling by invitation
2012 | Year | 12 | Month | 01 | Day |
2013 | Year | 03 | Month | 27 | Day |
Cognitive assessment
2013 | Year | 03 | Month | 27 | Day |
2013 | Year | 03 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012091